CSIMarket



Best Performing Stocks In Major Pharmaceutical Preparations Industry Today



 1 Day   Week  Current Month of June  30 Days 
Current Quarter Q2 of 2024  90 Days    Ytd    12 Months 
 

Shares fell by -0.87% on average, in Major Pharmaceutical Preparations Industry today.

Here are the best performing stocks in Major Pharmaceutical Preparations Industry.




RSPI

$0.0027

$0.0008 42.11%
Today's


RSPI

$0.0027

$0.0008 42.11%



Respirerx Pharmaceuticals Inc

Respirerx Pharmaceuticals Inc shares improved 42.11% today.


Respirerx Pharmaceuticals Inc is a pharmaceutical company that focuses on developing and commercializing therapeutics for the treatment of respiratory diseases. Their business model centers around research, development, and marketing of innovative respiratory drugs to improve patient outcomes and address unmet medical needs in this field.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.454 mill. $ - mill. $ -3.403 mill. 168 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 0.454 mill.


$ - mill.


$ -3.403 mill.

Employees Shares Outstanding P/E

-


168 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



CYCN

$2.7156

$0.6056 28.70%
Today's


CYCN

$2.7156

$0.6056 28.70%



Cyclerion Therapeutics Inc

Cyclerion Therapeutics Inc shares improved 28.70% today.


Cyclerion Therapeutics Inc*s business model focuses on developing and commercializing innovative therapies for serious and chronic diseases by targeting soluble guanylate cyclase (sGC).


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 7.566 mill. $ - mill. $ -17.100 mill. 3 mill. 1.26 Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 7.566 mill.


$ - mill.


$ -17.100 mill.

Employees Shares Outstanding P/E

-


3 mill.


1.26

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



CPMD

$0.0146

$0.0026 21.67%
Today's


CPMD

$0.0146

$0.0026 21.67%



Cannapharmarx Inc

Cannapharmarx Inc stock increased 21.67% today.


Cannapharmarx Inc operates on a business model centered around the production and distribution of pharmaceutical products derived from cannabis. They aim to leverage the medicinal properties of cannabis to develop innovative treatment options for various medical conditions. Their model involves extensive research and development, strategic partnerships, and adherence to strict regulatory guidelines for the safe and effective delivery of their products.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 5.385 mill. $ - mill. $ 3.688 mill. 369 mill. 597,813.38 Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 5.385 mill.


$ - mill.


$ 3.688 mill.

Employees Shares Outstanding P/E

-


369 mill.


597,813.38

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



LGVN

$3.19

$0.5000 18.59%
Today's


LGVN

$3.19

$0.5000 18.59%



Longeveron Inc

Longeveron Inc shares went up 18.59% today.


Longeveron Inc*s business model involves the development and commercialization of regenerative medicine products using mesenchymal stem cells for various medical conditions.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 6.756 mill. $ 0.800 mill. $ -20.231 mill. 2 mill. - Y/Y -43.40 %
Market Cap. Revenues TTM Net Income TTM

$ 6.756 mill.


$ 0.800 mill.


$ -20.231 mill.

Employees Shares Outstanding P/E

-


2 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -43.40 %


MRQ Y/Y - %



IRON

$46.27

$7.1100 18.16%
Today's


IRON

$46.27

$7.1100 18.16%



Disc Medicine Inc

Disc Medicine Inc stock went up 18.16% today.


Disc Medicine Inc is a biotechnology company that focuses on developing therapeutic treatments for hematologic diseases. Their business model revolves around leveraging their expertise in hepcidin biology to discover and develop small molecules that regulate iron metabolism. By targeting and modulating specific pathways, they aim to address unmet medical needs in conditions like iron overload disorders and anemia.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 1,125.139 mill. $ - mill. $ -74.079 mill. 24 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 1,125.139 mill.


$ - mill.


$ -74.079 mill.

Employees Shares Outstanding P/E

-


24 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



LPCN

$9.49

$1.3100 16.01%
Today's


LPCN

$9.49

$1.3100 16.01%



Lipocine Inc

Lipocine Inc shares increased 16.01% today.


Lipocine Inc is a pharmaceutical company focused on developing oral drug delivery systems for hormone therapeutics. Their business model involves conducting research and development to create innovative products that address unmet medical needs in areas such as testosterone replacement therapy and hypogonadism. The company aims to commercialize these proprietary drug candidates and collaborate with industry partners to enhance their potential reach and impact.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 49.679 mill. $ -2.851 mill. $ -16.352 mill. 5 mill. - Y/Y 164.58 %
Market Cap. Revenues TTM Net Income TTM

$ 49.679 mill.


$ -2.851 mill.


$ -16.352 mill.

Employees Shares Outstanding P/E

-


5 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 164.58 %


MRQ Y/Y - %



EPIX

$5.37

$0.7400 15.98%
Today's


EPIX

$5.37

$0.7400 15.98%



Essa Pharma inc

Essa Pharma Inc stock increased 15.98% today.


Essa Pharma Inc.*s business model revolves around the development of targeted small molecule therapeutics for the treatment of cancer. The company aims to address the unmet medical needs of patients with advanced and metastatic forms of prostate and breast cancer. By leveraging their expertise in clinical development and precision medicine, Essa Pharma aspires to bring innovative and effective treatments to market, ultimately improving patient outcomes.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 237.553 mill. $ - mill. $ -27.734 mill. 44 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 237.553 mill.


$ - mill.


$ -27.734 mill.

Employees Shares Outstanding P/E

18


44 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



SER

$11.01

$1.3600 14.09%
Today's


SER

$11.01

$1.3600 14.09%



Serina Therapeutics Inc

Serina Therapeutics Inc stock went up 14.09% today.





Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 30.718 mill. $ 0.138 mill. $ -21.812 mill. 3 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 30.718 mill.


$ 0.138 mill.


$ -21.812 mill.

Employees Shares Outstanding P/E

-


3 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



OCUL

$5.75

$0.7100 14.09%
Today's


OCUL

$5.75

$0.7100 14.09%



Ocular Therapeutix Inc

Ocular Therapeutix Inc stock improved 14.09% today.


Ocular Therapeutix Inc is a biopharmaceutical company that focuses on developing and commercializing innovative therapies for diseases and conditions of the eye. They utilize their proprietary hydrogel technology to design and manufacture sustained-release treatments that can be administered during routine eye exams and eliminate the need for patient compliance with eye drops.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 759.126 mill. $ 59.843 mill. $ -115.266 mill. 132 mill. - Y/Y 10.47 %
Market Cap. Revenues TTM Net Income TTM

$ 759.126 mill.


$ 59.843 mill.


$ -115.266 mill.

Employees Shares Outstanding P/E

-


132 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 10.47 %


MRQ Y/Y - %



RENB

$1.64

$0.1900 13.10%
Today's


RENB

$1.64

$0.1900 13.10%



Renovaro Inc

Renovaro Inc stock went up 13.10% today.


Renovaro Biosciences Inc is a biotechnology company that focuses on developing innovative therapies and technologies for regenerative medicine. Their business model involves conducting research and development, and partnering with pharmaceutical companies to bring their products to the market.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 176.268 mill. $ - mill. $ -53.927 mill. 107 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 176.268 mill.


$ - mill.


$ -53.927 mill.

Employees Shares Outstanding P/E

-


107 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



RNXT

$1.18

$0.1300 12.38%
Today's


RNXT

$1.18

$0.1300 12.38%



Renovorx Inc

Renovorx Inc shares went up 12.38% today.


Renovorx Inc is a medical technology company specializing in the development of innovative treatments for cardiovascular diseases. Their business model focuses on creating and commercializing minimally invasive therapies for patients suffering from conditions like myocardial infarction and heart failure. By leveraging cutting-edge medical devices and procedures, Renovorx aims to provide effective and efficient treatments that can significantly improve patient outcomes and quality of life.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 17.638 mill. $ - mill. $ -8.051 mill. 15 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 17.638 mill.


$ - mill.


$ -8.051 mill.

Employees Shares Outstanding P/E

-


15 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



PTIX

$1.03

$0.1030 11.11%
Today's


PTIX

$1.03

$0.1030 11.11%



Protagenic Therapeutics Inc new

Protagenic Therapeutics Inc New stock increased 11.11% today.


Protagenic Therapeutics Inc has developed a novel business model focused on the discovery and development of novel therapeutics targeting the PGRMC1 receptor, which plays a crucial role in various diseases. By leveraging their proprietary technology and partnerships, the company aims to advance the development of innovative drugs that can effectively treat a range of conditions influenced by the PGRMC1 receptor.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 4.568 mill. $ - mill. $ -6.007 mill. 4 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 4.568 mill.


$ - mill.


$ -6.007 mill.

Employees Shares Outstanding P/E

-


4 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



KPRX

$5.36

$0.5200 10.74%
Today's


KPRX

$5.36

$0.5200 10.74%



Kiora Pharmaceuticals Inc

Kiora Pharmaceuticals Inc shares improved 10.74% today.


Kiora Pharmaceuticals Inc operates with a business model focused on the research, development, and commercialization of innovative pharmaceutical products for various medical conditions and diseases. The company aims to create value through the discovery of new drugs, rigorous clinical trials, and strategic partnerships for ultimate patient benefit and sustainable growth.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 187.737 mill. $ 16.000 mill. $ 2.808 mill. 35 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 187.737 mill.


$ 16.000 mill.


$ 2.808 mill.

Employees Shares Outstanding P/E

-


35 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



URGN

$19.2

$1.7000 9.71%
Today's


URGN

$19.2

$1.7000 9.71%



Urogen Pharma Ltd

Urogen Pharma Ltd shares increased 9.71% today.


Urogen Pharma Ltd is a pharmaceutical company that specializes in developing and commercializing innovative therapies for urological and oncological conditions. Their business model revolves around conducting extensive research and development to create novel therapies, obtaining necessary regulatory approvals, and strategically partnering with healthcare providers and other stakeholders to market and distribute their products globally. By focusing on addressing unmet medical needs in the urology field, Urogen Pharma aims to improve patient outcomes and establish a strong presence in the market.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 640.892 mill. $ 83.213 mill. $ -104.317 mill. 33 mill. - Y/Y 5.01 %
Market Cap. Revenues TTM Net Income TTM

$ 640.892 mill.


$ 83.213 mill.


$ -104.317 mill.

Employees Shares Outstanding P/E

-


33 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 5.01 %


MRQ Y/Y - %



BFRI

$1.085

$0.0950 9.60%
Today's


BFRI

$1.085

$0.0950 9.60%



Biofrontera Inc

Biofrontera Inc shares went up 9.60% today.


Biofrontera Inc is a pharmaceutical company that specializes in developing and commercializing dermatological treatments for various skin conditions. Their business model revolves around research and development to create innovative products, obtaining regulatory approvals, and marketing and selling their products globally through direct sales teams and distribution partnerships. They aim to provide patients with effective and safe dermatological treatments while generating revenues through product sales.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ - mill. $ 88.794 mill. $ -28.002 mill. - mill. - Y/Y -68.99 %
Market Cap. Revenues TTM Net Income TTM

$ - mill.


$ 88.794 mill.


$ -28.002 mill.

Employees Shares Outstanding P/E

-


- mill.


-

Revenue Growth Income Growth

MRQ Y/Y -68.99 %


MRQ Y/Y - %



AMPE

$0.142

$0.0120 9.23%
Today's


AMPE

$0.142

$0.0120 9.23%



Ampio Pharmaceuticals inc

Ampio Pharmaceuticals Inc shares went up 9.23% today.


Ampio Pharmaceuticals Inc is a biopharmaceutical company primarily focused on the development of therapies for debilitating diseases. Their business model revolves around identifying unmet medical needs and developing innovative drug candidates to address these needs. They aim to create value through successful clinical development and commercialization of their products, ultimately benefiting patients and generating revenue for the company.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.115 mill. $ - mill. $ -8.632 mill. 1 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 0.115 mill.


$ - mill.


$ -8.632 mill.

Employees Shares Outstanding P/E

-


1 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



JAGX

$4.05

$0.3400 9.16%
Today's


JAGX

$4.05

$0.3400 9.16%



Jaguar Health Inc

Jaguar Health Inc stock went up 9.16% today.


Jaguar Health Inc*s business model revolves around developing and commercializing natural, plant-based products for human and animal health. They aim to provide innovative solutions utilizing their scientific expertise in the development of novel medicines and consumer healthcare products.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 643.311 mill. $ 10.140 mill. $ -38.872 mill. 159 mill. - Y/Y 19.22 %
Market Cap. Revenues TTM Net Income TTM

$ 643.311 mill.


$ 10.140 mill.


$ -38.872 mill.

Employees Shares Outstanding P/E

-


159 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 19.22 %


MRQ Y/Y - %



ATXI

$3.71

$0.3100 9.12%
Today's


ATXI

$3.71

$0.3100 9.12%



Avenue Therapeutics Inc

Avenue Therapeutics Inc stock went up 9.12% today.


Avenue Therapeutics Inc is a pharmaceutical company that focuses on the development and commercialization of intravenous (IV) opioids for acute pain management. They aim to address the needs of the hospital-based market by providing innovative and effective IV pain medications. Through research, clinical trials, and partnerships with healthcare providers, Avenue Therapeutics Inc strives to improve healthcare outcomes for patients suffering from acute pain conditions.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.028 mill. $ - mill. $ -7.235 mill. 0 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 0.028 mill.


$ - mill.


$ -7.235 mill.

Employees Shares Outstanding P/E

-


0 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



ANTX

$2.17

$0.1800 9.05%
Today's


ANTX

$2.17

$0.1800 9.05%



An2 Therapeutics Inc

An2 Therapeutics Inc shares increased 9.05% today.


An2 Therapeutics Inc is a biotechnology company that develops therapeutics for the treatment of rare diseases. Their business model focuses on research and development of innovative drugs that target specific genetic mutations responsible for these rare conditions, aiming to provide effective and personalized treatments. By collaborating with pharmaceutical partners and leveraging their expertise in drug discovery, An2 Therapeutics Inc aims to bring their therapies to market and improve the lives of patients with rare diseases.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 55.651 mill. $ - mill. $ -59.676 mill. 26 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 55.651 mill.


$ - mill.


$ -59.676 mill.

Employees Shares Outstanding P/E

-


26 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



CVKD

$0.4801

$0.0373 8.42%
Today's


CVKD

$0.4801

$0.0373 8.42%



Cadrenal Therapeutics Inc

Cadrenal Therapeutics Inc shares increased 8.42% today.


Cadrenal Therapeutics Inc*s business model revolves around the development and commercialization of innovative therapies in the field of renal diseases.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 7.392 mill. $ - mill. $ -28.201 mill. 15 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 7.392 mill.


$ - mill.


$ -28.201 mill.

Employees Shares Outstanding P/E

-


15 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



KA

$0.5095

$0.0395 8.40%
Today's


KA

$0.5095

$0.0395 8.40%



Kineta Inc

Kineta Inc shares went up 8.40% today.


Kineta Inc*s business model focuses on developing innovative therapeutics for various diseases, leveraging their expertise in immunology and drug discovery.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 5.981 mill. $ - mill. $ -74.869 mill. 12 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 5.981 mill.


$ - mill.


$ -74.869 mill.

Employees Shares Outstanding P/E

-


12 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



QLI

$0.7397

$0.0569 8.33%
Today's


QLI

$0.7397

$0.0569 8.33%



Qilian International Holding Group Limited

Qilian International Holding Group Limited shares improved 8.33% today.


Qilian International Holding Group Limited*s business model focuses on leveraging its extensive global network and expertise in the agriculture and local products industry to facilitate cross-border trade.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 26.444 mill. $ 45.751 mill. $ -8.122 mill. 36 mill. - Y/Y -29.46 %
Market Cap. Revenues TTM Net Income TTM

$ 26.444 mill.


$ 45.751 mill.


$ -8.122 mill.

Employees Shares Outstanding P/E

-


36 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -29.46 %


MRQ Y/Y - %



TLPH

$1.06

$0.0800 8.16%
Today's


TLPH

$1.06

$0.0800 8.16%



Talphera Inc

Talphera Inc stock increased 8.16% today.





Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 26.205 mill. $ - mill. $ -9.682 mill. 25 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 26.205 mill.


$ - mill.


$ -9.682 mill.

Employees Shares Outstanding P/E

-


25 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



BPTH

$2.16

$0.1600 8.00%
Today's


BPTH

$2.16

$0.1600 8.00%



Bio path Holdings Inc

Bio Path Holdings Inc shares improved 8.00% today.


Bio path Holdings Inc is a biotechnology company focused on developing RNA-based therapeutics for the treatment of diseases such as cancer. Their business model involves researching, developing, and commercializing these therapies to provide improved treatment options for patients.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 1.398 mill. $ - mill. $ -13.962 mill. 1 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 1.398 mill.


$ - mill.


$ -13.962 mill.

Employees Shares Outstanding P/E

-


1 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



AVRW

$0.0539

$0.0039 7.80%
Today's


AVRW

$0.0539

$0.0039 7.80%



Avenir Wellness Solutions Inc

Avenir Wellness Solutions Inc shares improved 7.80% today.


Avenir Wellness Solutions Inc is a health and wellness company that operates through a subscription-based model. They offer personalized wellness programs, incorporating nutrition, fitness, and mental health, to their members. With a focus on providing comprehensive and tailored services, Avenir Wellness Solutions Inc aims to promote overall well-being and help individuals achieve their health goals.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 3.490 mill. $ 4.575 mill. $ -4.530 mill. 65 mill. - Y/Y -89.88 %
Market Cap. Revenues TTM Net Income TTM

$ 3.490 mill.


$ 4.575 mill.


$ -4.530 mill.

Employees Shares Outstanding P/E

-


65 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -89.88 %


MRQ Y/Y - %



ZVSA

$5.25

$0.3700 7.58%
Today's


ZVSA

$5.25

$0.3700 7.58%



Zyversa Therapeutics Inc

Zyversa Therapeutics Inc shares went up 7.58% today.


Zyversa Therapeutics Inc*s business model revolves around developing innovative therapies and treatments for various medical conditions.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.327 mill. $ - mill. $ -16.195 mill. 0 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 0.327 mill.


$ - mill.


$ -16.195 mill.

Employees Shares Outstanding P/E

-


0 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



ORGS

$0.5798

$0.0398 7.37%
Today's


ORGS

$0.5798

$0.0398 7.37%



Orgenesis Inc

Orgenesis Inc stock increased 7.37% today.


Orgenesis Inc operates under a business model focused on the development and commercialization of technologies related to cell and gene therapies. They collaborate with academic institutions and hospitals to identify potential therapies, and then use their expertise in advanced manufacturing and cell therapy technologies to scale production and develop clinical protocols. Through partnerships and licensing agreements, Orgenesis aims to bring these innovative therapies to market and improve the lives of patients with chronic diseases.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 19.236 mill. $ -43,181.636 mill. $ 62.218 mill. 33 mill. 0.38 Y/Y -0.70 %
Market Cap. Revenues TTM Net Income TTM

$ 19.236 mill.


$ -43,181.636 mill.


$ 62.218 mill.

Employees Shares Outstanding P/E

111


33 mill.


0.38

Revenue Growth Income Growth

MRQ Y/Y -0.70 %


MRQ Y/Y -57.20 %



AIMD

$0.88

$0.0598 7.29%
Today's


AIMD

$0.88

$0.0598 7.29%



Ainos Inc

Ainos Inc stock improved 7.29% today.


Ainos Inc is a software development company that generates revenue by providing custom software solutions and consulting services to businesses. They offer tailored software solutions to address specific customer needs and provide consulting expertise to guide companies in optimizing their software development processes.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 5.079 mill. $ 0.094 mill. $ -14.565 mill. 6 mill. - Y/Y -57.84 %
Market Cap. Revenues TTM Net Income TTM

$ 5.079 mill.


$ 0.094 mill.


$ -14.565 mill.

Employees Shares Outstanding P/E

-


6 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -57.84 %


MRQ Y/Y - %



TOVX

$0.257

$0.0160 6.64%
Today's


TOVX

$0.257

$0.0160 6.64%



Theriva Biologics inc

Theriva Biologics Inc stock increased 6.64% today.


Theriva Biologics Inc operates as a biotechnology company that focuses on the discovery, development, and commercialization of innovative and targeted therapies for various diseases. Their business model is centered around research and development, aiming to create new biologic drugs and bring them to the market to address unmet medical needs.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 4.407 mill. $ - mill. $ -19.267 mill. 17 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 4.407 mill.


$ - mill.


$ -19.267 mill.

Employees Shares Outstanding P/E

-


17 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



MREO

$4.25

$0.2600 6.52%
Today's


MREO

$4.25

$0.2600 6.52%



Mereo Biopharma Group Plc

Mereo Biopharma Group Plc stock improved 6.52% today.


Mereo Biopharma Group Plc*s business model focuses on the development and commercialization of innovative therapeutics for rare diseases.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 2,422.217 mill. $ - mill. $ -34.196 mill. 570 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 2,422.217 mill.


$ - mill.


$ -34.196 mill.

Employees Shares Outstanding P/E

46


570 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



TNGX

$8.93

$0.5400 6.44%
Today's


TNGX

$8.93

$0.5400 6.44%



Tango Therapeutics Inc

Tango Therapeutics Inc shares went up 6.44% today.


Tango Therapeutics Inc is a biotechnology company that focuses on developing cancer therapies using DNA sequencing and computational biology. Their business model revolves around discovering and developing precision medicines by leveraging their expertise in genomics and biology to target specific cancer vulnerabilities.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 866.507 mill. $ 37.507 mill. $ -100.041 mill. 97 mill. - Y/Y 55.09 %
Market Cap. Revenues TTM Net Income TTM

$ 866.507 mill.


$ 37.507 mill.


$ -100.041 mill.

Employees Shares Outstanding P/E

-


97 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 55.09 %


MRQ Y/Y - %



ONCT

$8.7841

$0.4841 5.83%
Today's


ONCT

$8.7841

$0.4841 5.83%



Oncternal Therapeutics Inc

Oncternal Therapeutics Inc shares increased 5.83% today.


Oncternal Therapeutics Inc*s business model focuses on developing and commercializing novel therapies for the treatment of cancer.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 25.897 mill. $ 0.659 mill. $ -41.715 mill. 3 mill. - Y/Y -53.14 %
Market Cap. Revenues TTM Net Income TTM

$ 25.897 mill.


$ 0.659 mill.


$ -41.715 mill.

Employees Shares Outstanding P/E

-


3 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -53.14 %


MRQ Y/Y - %



PCSA

$1.75

$0.0957 5.78%
Today's


PCSA

$1.75

$0.0957 5.78%



Processa Pharmaceuticals Inc

Processa Pharmaceuticals Inc shares went up 5.78% today.


Processa Pharmaceuticals Inc is a biopharmaceutical company that operates by developing and commercializing innovative drug candidates for various medical conditions. They focus on advancing treatments through clinical trials, obtaining regulatory approvals, and partnering with other healthcare organizations for distribution and marketing.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 4.316 mill. $ - mill. $ -7.827 mill. 2 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 4.316 mill.


$ - mill.


$ -7.827 mill.

Employees Shares Outstanding P/E

-


2 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



AUPH

$5.65

$0.3000 5.61%
Today's


AUPH

$5.65

$0.3000 5.61%



Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc shares went up 5.61% today.


Aurinia Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing and commercializing therapies to treat autoimmune diseases such as lupus nephritis. Their business model revolves around conducting research and development to bring innovative medications to the market, securing partnerships and collaborations with other companies, and generating revenue through the sales of their products. By leveraging their expertise in the field, Aurinia aims to improve the lives of patients suffering from these diseases and achieve financial success through the commercialization of their therapies.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 813.673 mill. $ 191.407 mill. $ -62.563 mill. 144 mill. - Y/Y 46.19 %
Market Cap. Revenues TTM Net Income TTM

$ 813.673 mill.


$ 191.407 mill.


$ -62.563 mill.

Employees Shares Outstanding P/E

71


144 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 46.19 %


MRQ Y/Y - %



BYSI

$2.64

$0.1400 5.60%
Today's


BYSI

$2.64

$0.1400 5.60%



Beyondspring Inc

Beyondspring Inc stock increased 5.60% today.


Beyondspring Inc*s business model is focused on the development of innovative cancer therapies, specifically in the areas of immuno-oncology and targeted therapies.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 103.206 mill. $ 1.351 mill. $ -36.280 mill. 39 mill. - Y/Y 0.00 %
Market Cap. Revenues TTM Net Income TTM

$ 103.206 mill.


$ 1.351 mill.


$ -36.280 mill.

Employees Shares Outstanding P/E

-


39 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 0.00 %


MRQ Y/Y - %



TNXP

$1.15

$0.0600 5.50%
Today's


TNXP

$1.15

$0.0600 5.50%



Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals Holding Corp stock improved 5.50% today.


Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing and commercializing innovative therapies for psychiatric and neurological conditions. Their business model revolves around identifying potential drug candidates, conducting preclinical and clinical trials to evaluate their efficacy and safety, and ultimately obtaining regulatory approval for their products to bring them to market. Through strategic partnerships and collaborations, they aim to commercialize and distribute their therapies to provide much-needed treatment options for patients.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 93.011 mill. $ 10.250 mill. $ -102.616 mill. 81 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 93.011 mill.


$ 10.250 mill.


$ -102.616 mill.

Employees Shares Outstanding P/E

-


81 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



SNPX

$4.61

$0.2400 5.49%
Today's


SNPX

$4.61

$0.2400 5.49%



Synaptogenix Inc

Synaptogenix Inc stock increased 5.49% today.


Synaptogenix Inc is a biotechnology company focused on developing innovative therapeutics for the treatment of neurodegenerative diseases. Their business model revolves around conducting research and clinical trials to identify and develop novel drugs that target the underlying mechanisms of these diseases. By collaborating with academic institutions and utilizing their expertise, the company aims to eventually commercialize their drug candidates for the benefit of patients worldwide.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.191 mill. $ - mill. $ -14.182 mill. 0 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 0.191 mill.


$ - mill.


$ -14.182 mill.

Employees Shares Outstanding P/E

-


0 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



IXHL

$3.32

$0.1700 5.40%
Today's


IXHL

$3.32

$0.1700 5.40%



Incannex Healthcare Inc

Incannex Healthcare Inc shares increased 5.40% today.





Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 52.699 mill. $ - mill. $ 0.848 mill. 16 mill. 0.10 Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 52.699 mill.


$ - mill.


$ 0.848 mill.

Employees Shares Outstanding P/E

-


16 mill.


0.10

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



AXIM

$0.0082

$0.0004 5.13%
Today's


AXIM

$0.0082

$0.0004 5.13%



Axim Biotechnologies Inc

Axim Biotechnologies Inc stock went up 5.13% today.


Axim Biotechnologies Inc*s business model revolves around developing and commercializing innovative pharmaceutical and nutraceutical products, primarily focusing on cannabinoid-based therapies.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 2.397 mill. $ 0.085 mill. $ -5.589 mill. 292 mill. - Y/Y 616.22 %
Market Cap. Revenues TTM Net Income TTM

$ 2.397 mill.


$ 0.085 mill.


$ -5.589 mill.

Employees Shares Outstanding P/E

-


292 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 616.22 %


MRQ Y/Y - %



VIRX

$0.6738

$0.0321 5.00%
Today's


VIRX

$0.6738

$0.0321 5.00%



Viracta Therapeutics Inc

Viracta Therapeutics Inc shares improved 5.00% today.


Viracta Therapeutics Inc is a biopharmaceutical company focused on developing targeted therapies for viral-associated cancers. The company aims to advance research, develop innovative treatments, and commercialize products to improve the lives of patients suffering from these types of cancers.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 26.065 mill. $ - mill. $ -68.747 mill. 39 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 26.065 mill.


$ - mill.


$ -68.747 mill.

Employees Shares Outstanding P/E

-


39 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %




 1 Day   Week  Current Month of June  30 Days 
Current Quarter Q2 of 2024  90 Days    Ytd    12 Months 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com